Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
09/2003
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics
09/24/2003EP1345905A1 Potassium channel inhibitors
09/24/2003EP1345892A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives
09/24/2003EP1345891A1 Glucagon antagonist/inverse agonist
09/24/2003EP0923543B1 Potassium channel inhibitors
09/24/2003CN1444571A Urethane derivatives
09/24/2003CN1444561A Acetamide derivatives and use thereof as inhibitors of coagulation factors XA and VIIA
09/24/2003CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides
09/24/2003CN1444477A Thrombopoietin mimetics
09/23/2003US6624177 Treating diseases in which matrix melatoproteinases are involved such as multiple sclerosis, atherosclerotic plaque rupture, restenosis, aortic aneurism, heart failure, periodontal disease, corneal ulceration, burns, decubital
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6624117 Organic electron acceptor (developer) and colorless or pale colored electron donative compound (color forming compound)
09/23/2003US6623914 Method for preparing an acid salt of p-phenylenediamine-type photographic color developers
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/23/2003CA2086654C Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them
09/18/2003WO2003076451A1 Ferrocenyl ligands and the use thereof in catalysis
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076391A2 Urokinase inhibitors, production and use thereof
09/18/2003WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003US20030176509 Methods and products related to 16-HETE analogs
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/17/2003EP1344771A1 2-alkoxy-phenylsulphonic acid derivatives as intermediates for herbicidal sulphonylamino(thio)carbonyl compounds
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1343781A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/17/2003EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
09/17/2003EP1343753A2 Antimicrobial agents
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003EP1133471B1 Hydrazine derivatives
09/17/2003EP1119529B1 Chemical constructs
09/17/2003EP0906293B1 Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides
09/17/2003EP0668762B1 Isobutenyl-substituted taxanes and their pharmaceutical compositions
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
09/17/2003CN1443159A Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for production thereof
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1443154A 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/17/2003CN1121392C Substituted pyrimidine (thi) ones
09/17/2003CN1121374C Novel trienoic retinoid compounds and method
09/16/2003US6620933 Dyes having acid reistance and stability used as colors for silver halide photographic, photosensitive materials, ink jet or thermal printing and as toners in electrophotography, electroluminescence or television displays
09/16/2003US6620920 Anisotropic polymers having branchings which can absorb electromagnetic waves, used for optical signal processing; birefringence
09/16/2003US6620835 Method of inhibiting matrix metalloproteinases
09/16/2003US6620827 PPARγ modulators
09/16/2003US6620813 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
09/16/2003US6620546 Ionic composition comprising salt having conductivity of greater than 10-5 S.cm-1 between -30 and 150 degrees C; cation is proton, hydronium, hydroxonium, nitrosonium, ammonium or metal cation; anion is carbanion containing fluorine
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2215695C .beta.-sheet mimetics and use thereof as protease inhibitors
09/12/2003WO2003074479A1 Semicarbazide derivatives and their use as antithrombotics
09/12/2003WO2003074475A2 Substituted aryl ketones
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/12/2003WO2003074038A1 Methods for treating diseases related to intraocular pressure
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2478528A1 Semicarbazide derivatives and the use thereof as antithrombotics
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477392A1 Methods for treating diseases related to intraocular pressure
09/11/2003US20030171585 Anti-inflammatory compounds
09/11/2003US20030171579 N-benzyl-N'-phenylurea derivatives; inhibitors of the coagulation factors Xa and VIIa
09/11/2003US20030171422 Aldose reductase inhibitors; antidiabetic agents
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030171351 2'-substituted 1,1'-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
09/11/2003US20030171350 Sulphonamide derivatives
09/11/2003US20030171341 Method for modulating the activity of a Rho C enzyme, comprising: contacting said Rho C enzyme with an effective amount of a compound of formula 1:
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/10/2003EP1341797A1 Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catayltic reactions
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP1341754A1 Substituted anthranilic acids
09/10/2003EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/10/2003EP1145078B1 Photographic couplers having improved image dye light stability
09/10/2003EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion
09/10/2003EP0939627B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003EP0896533B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors
09/10/2003CN1441770A Modified forms of pharmacologically active agents and uses therefor
09/10/2003CN1441702A Composition and compound based on metal and acid salts having sulphonyl group borne by perhalogenated carbon and their use as Lewis acid
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/09/2003US6617461 Process for preparation of optically active N-substituted azetidine-2-carboxylic acids
09/09/2003US6617351 Amide, carbamate, and urea derivatives
09/09/2003US6617350 Inhibitors of aspartyl protease
09/04/2003WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003WO2003072532A1 Ester compound and medicinal use thereof
09/04/2003WO2003072063A2 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
09/04/2003WO2003072062A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166694 Glycinamides
09/04/2003US20030166693 Benzene derivatives and pharmaceutical use thereof
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/03/2003EP1339684A1 Mch antagonists and their use in the treatment of obesity
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339668A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/03/2003EP1339663A2 Naphthalene derivatives
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 177